Avadel Pharmaceuticals PLC (AVDL)
18.29
-0.02
(-0.11%)
USD |
NASDAQ |
May 02, 16:00
18.29
0.00 (0.00%)
After-Hours: 17:12
Avadel Pharmaceuticals Total Assets (Quarterly): 164.70M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 164.70M |
| September 30, 2023 | 203.10M |
| June 30, 2023 | 200.98M |
| March 31, 2023 | 140.74M |
| December 31, 2022 | 132.78M |
| September 30, 2022 | 145.76M |
| June 30, 2022 | 157.94M |
| March 31, 2022 | 221.13M |
| December 31, 2021 | 247.26M |
| September 30, 2021 | 264.09M |
| June 30, 2021 | 282.59M |
| March 31, 2021 | 292.94M |
| December 31, 2020 | 311.64M |
| September 30, 2020 | 327.64M |
| June 30, 2020 | 341.40M |
| March 31, 2020 | 207.72M |
| December 31, 2019 | 151.44M |
| September 30, 2019 | 155.89M |
| June 30, 2019 | 165.71M |
| March 31, 2019 | 173.62M |
| December 31, 2018 | 190.30M |
| September 30, 2018 | 269.01M |
| June 30, 2018 | 295.24M |
| March 31, 2018 | 351.86M |
| December 31, 2017 | 253.28M |
| Date | Value |
|---|---|
| September 30, 2017 | 277.43M |
| June 30, 2017 | 259.16M |
| March 31, 2017 | 258.69M |
| December 31, 2016 | 245.48M |
| September 30, 2016 | 247.98M |
| June 30, 2016 | 249.71M |
| March 31, 2016 | 255.01M |
| December 31, 2015 | 215.08M |
| June 30, 2015 | 186.55M |
| March 31, 2015 | 186.41M |
| December 31, 2014 | 174.20M |
| September 30, 2014 | 164.38M |
| June 30, 2014 | 174.63M |
| March 31, 2014 | 181.74M |
| December 31, 2013 | 116.25M |
| September 30, 2013 | 116.51M |
| June 30, 2013 | 118.41M |
| March 31, 2013 | 122.73M |
| December 31, 2012 | 117.31M |
| June 30, 2012 | 133.72M |
| March 31, 2012 | 137.41M |
| December 31, 2011 | 69.40M |
| September 30, 2011 | 72.70M |
| June 30, 2011 | 76.11M |
| March 31, 2011 | 69.98M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
132.78M
Minimum
Dec 2022
341.40M
Maximum
Jun 2020
216.60M
Average
203.10M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Trinity Biotech PLC | 59.44M |
| Medtronic PLC | 90.84B |
| Akari Therapeutics PLC | 4.355M |
| Biophytis SA | 13.22M |
| TC BioPharm (Holdings) PLC | 11.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 76.96M |
| Shareholders Equity (Quarterly) | 87.74M |
| Current Ratio | 3.641 |
| Net Debt Paydown Yield | 2.15% |